Press releases 2007
Search here for press releases from Priveq Investment and our portfolio companies, sorted in chronological order.
28-11-2007
Mentice – growth company of the year 2007
Mentice has been awarded as the best growth company 2007 in the Gothenburg region – an award received from the organisation Business Region Göteborg, on November 27. This is not the first award for the company – in 2004 Mentice was titled “runner up company of the year” and was also awarded by the Swedish Trade Council in 2005. Mentice develops and sells medical simulators all over the world and has grown at an average rate of more than 70 percent per year since the start in 1999.

Read more 

25-10-2007
Swedish Orphan International takes over the worldwide rights for Multiferon - acquires the assets in ViraNative AB
The pharmaceutical company Swedish Orphan International AB today took over the assets in ViraNative AB, a biotech company based in Umeå, Sweden. ViraNative AB filed for bankruptcy in September and Swedish Orphan International acquired the bankruptcy estade today. Through the take over Swedish Orphan International acquires the worldwide rights for the drug Multiferon, approved in Sweden for the treatment of malignant melanoma, and ensures future supply of the drug to patients across the world.

Read more 

03-07-2007
Priveq invests in Sydtotal - one of Sweden´s highest-growth ventilation installers
Priveq is becoming the main shareholder of Sydtotal, one of the leading ventilation installers in southern Sweden with sales of approximately SEK 500 m.

Read more 

07-06-2007
Priveq Investment divests its holding in Scandinavian Photo
After nearly seven years as a partner of photography reseller Scandinavian Photo, Priveq has divested its 40 % equity holding.

Read more 

28-03-2007
Priveq Investment exits Hemtex
Priveq has divested its remaining holdings in listed company Hemtex

Read more 

PRIVEQ INVESTMENT | Box 5295, SE-102 46 Stockholm, Sweden | Visitors: Riddargatan 17 | Tel: +46 (0)8 459 67 60 | Fax: +46 (0)8 20 35 66 | info@priveq.se